Bill Ackman - Pershing Square Capital Management
As of Q2 2026, Bill Ackman reported 14 long-equity positions worth $19.47B in aggregate.
Copy-investor backtest
- Latest quarter
- +1.96%
- 1-year
- +15.11%
- 3-year
- +41.35%
- 5-year
- +50.23%
- 3-year vs S&P 500
- -31.89%
- 5-year vs S&P 500
- -23.45%
- 5-year top 5
- +52.69%
Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.
Get email alerts when Bill Ackman files a new 13F — sign in or create a free account.
Updated 2026-06-06 from SEC 13F data.
Live quotes available for 4 of 9 rows. Rows without a quote are marked unavailable.
| 1 | VRX | VALEANT PHARMACEUTICALS INTL | 25.84% | New | 19,473,933 | $3.87B | No quote | No quote |
| 2 | APD | AIR PRODS & CHEMS INC | 20.77% | - | 20,549,076 | $3.11B | $151.28 | No quote |
| 3 | CP | CANADIAN PAC RY LTD | 17.01% | - | 13,940,890 | $2.55B | $182.70 | No quote |
| 4 | ZTS | ZOETIS INC | 12.93% | Add +0.6% | 41,823,145 | $1.94B | $46.29 | No quote |
| 5 | QSR | RESTAURANT BRANDS INTL INC | 9.75% | - | 38,003,984 | $1.46B | $38.41 | No quote |
| 6 | PAH | PLATFORM SPECIALTY PRODS COR | 7.33% | - | 42,737,394 | $1.1B | No quote | No quote |
| 7 | HHC | HOWARD HUGHES CORP | 3.69% | - | 3,568,017 | $553.11M | No quote | No quote |
| 8 | ACTZZZZ | ACTAVIS PLC | 2.68% | New | 1,348,358 | $401.3M | No quote | No quote |
| 9 | AGN | ALLERGAN INC | - | Sold | 0 | $0 | No quote | No quote |